PharmaResearch Co Ltd

XKRX:214450 (Korea (the Republic of))  
â‚© 135900.00 (-1.52%) May 21
18.64
P/B:
3.19
Market Cap:
â‚© 1.39T ($ 1.01B)
Enterprise V:
â‚© 1.26T ($ 920.84M)
Volume:
165.65K
Avg Vol (2M):
271.89K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for PharmaResearch Co Ltd ( XKRX:214450 ) from 2015 to May 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. PharmaResearch stock (XKRX:214450) PE ratio as of May 22 2024 is 18.64. More Details

PharmaResearch Co Ltd (XKRX:214450) PE Ratio (TTM) Chart

To

PharmaResearch Co Ltd (XKRX:214450) PE Ratio (TTM) Historical Data

Total 1257
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
PharmaResearch PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-22 18.4 2024-03-14 12.5
2024-05-21 18.4 2024-03-13 12.4
2024-05-20 18.6 2024-03-12 12.1
2024-05-17 18.6 2024-03-11 11.9
2024-05-16 18.5 2024-03-08 11.9
2024-05-14 19.8 2024-03-07 12.0
2024-05-13 19.0 2024-03-06 12.3
2024-05-10 19.3 2024-03-05 12.3
2024-05-09 19.0 2024-03-04 12.4
2024-05-08 18.3 2024-02-29 12.6
2024-05-07 18.2 2024-02-28 12.7
2024-05-03 18.9 2024-02-27 12.3
2024-05-02 17.4 2024-02-26 12.8
2024-04-30 17.2 2024-02-23 12.7
2024-04-29 17.4 2024-02-22 12.3
2024-04-26 16.0 2024-02-21 12.7
2024-04-25 15.3 2024-02-20 12.2
2024-04-24 15.6 2024-02-19 12.3
2024-04-23 15.9 2024-02-16 12.9
2024-04-22 16.9 2024-02-15 12.8
2024-04-19 17.5 2024-02-14 12.8
2024-04-18 17.0 2024-02-13 13.0
2024-04-17 17.3 2024-02-08 13.8
2024-04-16 16.8 2024-02-07 13.4
2024-04-15 17.0 2024-02-06 13.5
2024-04-12 17.2 2024-02-05 13.1
2024-04-11 16.7 2024-02-02 13.5
2024-04-09 16.0 2024-02-01 13.9
2024-04-08 14.9 2024-01-31 14.1
2024-04-05 15.3 2024-01-30 14.5
2024-04-04 14.8 2024-01-29 14.4
2024-04-03 14.6 2024-01-26 15.0
2024-04-02 14.0 2024-01-25 15.1
2024-04-01 14.6 2024-01-24 15.1
2024-03-29 13.6 2024-01-23 15.2
2024-03-28 13.4 2024-01-22 15.0
2024-03-27 13.3 2024-01-19 15.7
2024-03-26 13.1 2024-01-18 15.6
2024-03-25 13.2 2024-01-17 15.2
2024-03-22 12.2 2024-01-16 15.7
2024-03-21 12.2 2024-01-15 16.0
2024-03-20 12.3 2024-01-12 16.1
2024-03-19 12.5 2024-01-11 16.1
2024-03-18 12.4 2024-01-10 16.2
2024-03-15 12.2 2024-01-09 15.2

PharmaResearch Co Ltd (XKRX:214450) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
PharmaResearch Co Ltd formerly Pharma Research Products Co Ltd is a bio pharmaceutical firm which realizes a new treatment paradigm for regenerative medicine. Its products include Rejuran, Rejuvenex, and Re-An eye drops. It also provides medical devices, cosme ceuticals, and dietary supplements.